LET-60 RAS inhibitors belong to a class of chemical compounds specifically designed to target and modulate the activity of the LET-60 RAS protein, also known as Ras GTPase LET-60. RAS proteins are pivotal components of cell signaling pathways, particularly in regulating cell growth, proliferation, and differentiation. The LET-60 RAS protein is a key member of this family and is highly conserved across various species, from nematodes to humans. Inhibitors designed to target LET-60 RAS are primarily employed in molecular and cellular biology research to investigate the functional properties and regulatory mechanisms associated with this protein.
The development of LET-60 RAS inhibitors typically involves a combination of biochemical, biophysical, and structural approaches aimed at identifying or designing molecules that can selectively interact with LET-60 RAS and modulate its activity within cellular signaling pathways. By inhibiting LET-60 RAS, these compounds can disrupt its role as a molecular switch that toggles between an active GTP-bound state and an inactive GDP-bound state, thereby impacting downstream signaling events. Researchers use LET-60 RAS inhibitors to explore the intricate roles played by this protein in cellular functions, attempting to unravel its contributions to cell cycle regulation, proliferation, and differentiation processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Sulindac | 38194-50-2 | sc-202823 sc-202823A sc-202823B | 1 g 5 g 10 g | $32.00 $86.00 $150.00 | 3 | |
Sulindac metabolites can inhibit Ras signaling indirectly, which might lead to reduced expression of LET-60 RAS through feedback loops. | ||||||
Lovastatin | 75330-75-5 | sc-200850 sc-200850A sc-200850B | 5 mg 25 mg 100 mg | $29.00 $90.00 $339.00 | 12 | |
Lovastatin inhibits HMG-CoA reductase, potentially affecting the prenylation and function of RAS, which may influence LET-60 RAS expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, which could disrupt downstream signaling pathways and indirectly decrease LET-60 RAS expression. | ||||||
Manumycin A | 52665-74-4 | sc-200857 sc-200857A | 1 mg 5 mg | $219.00 $634.00 | 5 | |
Manumycin A is a farnesyltransferase inhibitor, which can block RAS prenylation and possibly reduce LET-60 RAS expression levels. | ||||||
Tipifarnib | 192185-72-1 | sc-364637 | 10 mg | $720.00 | ||
Tipifarnib, an inhibitor of farnesyltransferase, might interfere with RAS processing and indirectly decrease LET-60 RAS expression. | ||||||
Lonafarnib | 193275-84-2 | sc-482730 sc-482730A | 5 mg 10 mg | $173.00 $234.00 | ||
Lonafarnib is another farnesyltransferase inhibitor, potentially affecting RAS function and indirectly its expression. | ||||||